Obesity animal model and methods for making and using thereof
US-2015208620-A1 · Jul 30, 2015 · US
US10130080B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10130080-B2 |
| Application number | US-201314420410-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 1, 2013 |
| Priority date | Aug 8, 2012 |
| Publication date | Nov 20, 2018 |
| Grant date | Nov 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The application provides, among others, methods for constructing animal obesity models, methods for screening microorganism or composition of microorganisms that may cause obesity, methods for screening therapeutic targets for treating metabolic disorders, and methods for screening or evaluating microorganisms, compounds, food, recipes, formulations, drugs, nutritional supplements, healthcare products, beverages and other items for preventing and treating metabolic diseases.
Opening claim text (preview).
What is claimed is: 1. A method for establishing a non-human obesity animal model that develops obesity, the method comprising, inoculating a non-human germ-free animal with Enterobacter cloacea 29, and feeding the inoculated animal with a diet having at least 34.9% of fat content for a period of time to provide the non-human obesity animal model. 2. The method of claim 1 , wherein the non-human obesity animal model manifests a metabolic syndrome comprising at least one of obesity, insulin resistance, or chronic inflammation. 3. The method of claim 1 , wherein the non-human obesity animal model is a mouse, a rat, a rabbit, a monkey, a pig, or a Guinean pig. 4. The method of claim 1 , wherein the inoculating the non-human germ-free animal comprises inoculating the non-human germ-free animal by at least one of intragastric administration, topical administration, or oral administration. 5. The method of claim 1 , wherein the inoculating the non-human germ-free animal comprises inoculating the non-human germ-free animal with at least 10 2 bacteria cells.
Chimeric vertebrates, e.g. comprising exogenous cells · CPC title
Animal models for infectious diseases · CPC title
Murine · CPC title
Animal model for inflammation · CPC title
Animals on a special diet · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.